Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Alefarm Brewing FY26 H1 pretax result swings to profit of DKK 110,000; revenue rises 12.8% to DKK 6.3 million

Alefarm Brewing FY26 H1 pretax result swings to profit of DKK 110,000; revenue rises 12.8% to DKK 6.3 million

ReutersReuters2026/08/27 07:07
  • Alefarm Brewing posted first-half 2026 revenue of DKK 6.3 million, up 12.8% year over year.
  • EBITDA climbed to DKK 754,000 from DKK 111,000, while profit before tax swung to DKK 110,000 from a loss.
  • Gross profit rose 39.5% to DKK 2.54 million; capacity costs fell nearly 10%.
  • On-trade sales to restaurants and bars more than doubled, helped by a Copenhagen restaurant-chain deal and the March Taproom opening.
  • Full-year 2026 outlook kept revenue at about DKK 13-14 million; EBITDA guidance raised to about DKK 1.25-1.75 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alefarm Brewing A/S published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas